Lipocine (NASDAQ:LPCN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Lipocine (LPCN) operate in?

Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.

Open	$3.50
Close	$3.38
Volume / Avg.	16.37K / 32.35K
Day Range	$3.36 - $3.50
52 Wk Range	3.20 - 11.79
Market Cap	$19.52M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	1.5%
Days to Cover	2.06

Recent News

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Lisa Levin

Why Lipocine Stock Is Moving Higher Today?

Lipocine Inc (NASDAQ: LPCN) shares are trading higher after the company released topline results from a Phase 2 clinical study of LPCN 1148, an oral candidate under development for the

Vandana Singh

Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in Q1 sales.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.50
Close	$3.38
Volume / Avg.	16.37K / 32.35K
Day Range	$3.36 - $3.50
52 Wk Range	3.20 - 11.79
Market Cap	$19.52M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	1.5%
Days to Cover	2.06

About Lipocine Inc

Sector

Health Care

Industry

Pharmaceuticals

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery tech...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lipocine (LPCN) stock?

You can purchase shares of Lipocine (NASDAQ:LPCN) through any online brokerage.

View our list of the best stock brokerages

Who are Lipocine (LPCN) competitors?

Other companies in Lipocine’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Jaguar Health (NASDAQ:JAGX).

What is the forecast, or price target, for Lipocine (LPCN) stock?

Lipocine has a consensus price target of $21.50.

What is the current price for Lipocine (LPCN)?

The stock price for Lipocine (NASDAQ: LPCN) is $3.65 last updated February 20, 2025 at 8:00 AM EST.

Does Lipocine (LPCN) pay a dividend?

There are no upcoming dividends for Lipocine.

When is Lipocine (NASDAQ:LPCN) reporting earnings?

Lipocine’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Lipocine (LPCN) going to split?

There is no upcoming split for Lipocine.

What sector and industry does Lipocine (LPCN) operate in?

Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Lipocine

Lipocine (LPCN) Forecast